Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are already part of the SNIFF patient group at Angers hospital, where fatty liver disease (NASH) is suspected and a liver biopsy and MRI scan have been requested by a liver specialist as part of their initial assessment
- People who are adults (18 years of age or older)
- People who have given their free and informed verbal agreement to take part in the study
Who may not be able to join:
- People for whom an MRI scan is not safe or suitable (confirm with trial site)
- People where more than 3 months have passed between the assessment of their liver condition and the MRI scan being done
- People who are pregnant, in labour, or currently breastfeeding
- People who are currently detained or restricted by a court or government authority
- People who are receiving psychiatric care under compulsion (i.e., without their full free choice)
- People who are under a legal protection order (confirm with trial site)
- People who are not enrolled in or covered by a social security or health insurance scheme
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anita PAISANT, MD, University Hospital, Angers
Phone: 0241353637
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of the diagnostic performance of new MRI biomarkers for NASH diagnosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.